🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07744594
Starting soon Not applicable

Study on Dynamic Multimodal Analgesia Regimen Integrated With Traditional Chinese and Western Medicine After Perianal Abscess Surgery

NCT07744594 · tracked via the Priya Life Science China tracker
Sponsor
The Affiliated Hospital of Putian University
Phase
Not applicable
Started
2026-07-30
Last updated
2026-08-04

Condition(s) studied

Perianal Abscess

Investigational drug(s) / intervention(s)

TCM sitz bath

TCM sitz bath: TCM sitz bath

Study summary

Background:Perianal abscess is a common acute anorectal pyogenic disease (8%-25% of anorectal illnesses), mainly seen in men aged 20-40. Over 90% suffer severe postoperative pain, impairing healing, triggering anxiety or sepsis and raising medical loads. Western multimodal analgesia eases pain yet causes dependence and side effects. TCM sitz baths clear heat, reduce swelling and promote recovery. Few personalized combined protocols are available, and integrated Chinese-Western synergies are insufficiently exploited. This optimized integrated intervention guides postoperative pain nursing.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Aged between 18 and 75 years old (18 ≤ age ≤ 75); 2. Diagnosed with primary perianal abscess via digital rectal examination, anorectal ultrasound or MRI, and scheduled for incision and drainage or radical surgery; 3. The maximum diameter of the abscess cavity ≥ 2 cm, or with obvious abscess cavity formation; 4. Patients are willing and capable of participating in the pain management protocol, fully understand the significance of pain management, and can actively cooperate with study procedures; 5. No severe coagulation disorders. Exclusion Criteria: 1. Complicated with specific infectious diseases such as Crohn's disease and tuberculosis; 2. Unclear source of postoperative pain, i.e., the origin of pain cannot be confirmed or the pain is unrelated to surgery; 3. Presence of definite contraindications, including drug allergy or inability to tolerate any pain management measures adopted in this trial; 4. Pregnant or lactating women; 5. Patients unable to cooperate with the study, such as those with cognitive impairment, history of mental illness, communication barriers and other conditions; 6. Patients with long-term analgesic medication use and established drug tolerance; 7. Complicated with uncontrolled cardiovascular and cerebrovascular diseases (NYHA cardiac function class Ⅲ-Ⅳ), hepatic and renal insufficiency (Child-Pugh class C or eGFR \< 30 mL/min/1.73 m²), etc.; 8. Abscess secondary to rectal neoplasms, trauma or iatrogenic injury; 9. Severe postoperative complications (such as massive hemorrhage, sepsis) or concurrent infections at other sites; 10. Patients receiving only non-surgical treatments such as simple needle aspiration of pus.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Affiliated Hospital of Putian University Putian Fujian

More The Affiliated Hospital of Putian University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07744594 on ClinicalTrials.gov ↗ ← All trials in China